SCHEMBL33377976

SCHEMBL33377976

CC(C)c1cnn2c(Nc3cccnc3)cc(Cl)nc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 11/20 0.42
▸ GSK3B P49841 6/20 0.42
▸ CDK5 Q00535 2/20 0.41
▸ CDK5R1 Q15078 2/20 0.41
▸ CCNA2 P20248 2/20 0.41
▸ CCNA1 P78396 1/20 0.41
▸ DYRK1A Q13627 1/20 0.41
▸ CDK7 P50613 3/20 0.38
▸ HTR2A P28223 1/20 0.37
▸ HTR2C P28335 1/20 0.37
▸ CSNK2A1 P68400 1/20 0.36
▸ CDK9 P50750 2/20 0.36
▸ CDK6 Q00534 2/20 0.36
▸ CCNT1 O60563 1/20 0.36
▸ CDK1 P06493 1/20 0.36
▸ CDK4 P11802 1/20 0.36
▸ CCNB1 P14635 1/20 0.36
▸ CCND1 P24385 1/20 0.36
▸ CCNE1 P24864 1/20 0.36
▸ CDK8 P49336 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL33377983 0.85 CDK2 (0.43) CDK2GSK3BCDK5CDK5R1CCNA2
SCHEMBL13998500 0.83 AHR (0.50) CDK2GSK3BCCNE1NPC1ALDH1A1
SCHEMBL33377930 0.83 CDK7 (0.56) CDK2GSK3BCDK5CDK5R1CCNA2
SCHEMBL18122642 0.83 CDK2 (0.42) CDK2GSK3BCDK5CDK5R1DYRK1A
SCHEMBL13998583 0.82 GSK3B (0.49) CDK2GSK3BCCNE1
SCHEMBL33377917 0.81 CDK7 (0.46) CDK2GSK3BCDK5CDK5R1DYRK1A
SCHEMBL24962513 0.81 GSK3B (0.61) CDK2GSK3BCDK5CDK5R1DYRK1A
SCHEMBL30209082 0.81 GSK3B (0.61) CDK2GSK3BCDK5CDK5R1DYRK1A
SCHEMBL33378035 0.81 CDK2 (0.40) CDK2GSK3BCDK5CDK5R1DYRK1A
SCHEMBL33377883 0.80 CDK2 (0.43) CDK2GSK3BCDK5CDK5R1CCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4717312-A1 PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2026-04-01 — — EP disclosed
Send feedback